The role of antibiotics in the treatment of periodontitis (Part 2--Controlled drug delivery).
Since last reviewing the field, controlled release products have made the jump from research to clinical practice. The potential to extend the efficacy of periodontal therapy with such products is exciting, but also needs careful evaluation. This review will look at recent developments and also will examine the eventual place for these products in periodontics.
Needleman
I G
IG
Department of Periodontology, London Hospital Medical College, London, UK.
Pandya
N V
NV
Smith
S R
SR
Foyle
D M
DM
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems; D005782:Gels; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D008911:Minocycline / Q000627:therapeutic use; D010347:Patient Care Planning; D018579:Patient Selection; D010514:Periodontal Pocket / Q000188:drug therapy; D010518:Periodontitis / Q000188:drug therapy*; D011145:Polyvinyls / Q000627:therapeutic use; D016745:Root Planing; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D005782:Gels; D011145:Polyvinyls; D008795:Metronidazole; C016438:ethylenevinylacetate copolymer; D013752:Tetracycline; D008911:Minocycline